-transparent.png){kind=logo}
The hypotensive effect of penbutolol, a new beta-adrenergic blocking drug, has been evaluated in a doulbe-blind crossover trial on 15 patients. Blood pressures were significantly lower during active drug treatment (P less than 0.001), the average reduction being: 1.7/0.9 kPa (13/7 mmHg) erect.
Related Publications
J H Bett, and
R K Wilkinson, and
J Williams, and
H Ryan
April 1990,
DICP : the annals of pharmacotherapy,
J H Bett, and
R K Wilkinson, and
J Williams, and
H Ryan
December 1978,
British journal of clinical pharmacology,
J H Bett, and
R K Wilkinson, and
J Williams, and
H Ryan
April 1978,
Annals of clinical research,
J H Bett, and
R K Wilkinson, and
J Williams, and
H Ryan
May 1985,
Medicina clinica,
J H Bett, and
R K Wilkinson, and
J Williams, and
H Ryan
January 1979,
Medicina,
J H Bett, and
R K Wilkinson, and
J Williams, and
H Ryan
February 1976,
The Practitioner,
J H Bett, and
R K Wilkinson, and
J Williams, and
H Ryan
January 1970,
The Medical journal of Australia,
J H Bett, and
R K Wilkinson, and
J Williams, and
H Ryan
May 1973,
Ugeskrift for laeger,
J H Bett, and
R K Wilkinson, and
J Williams, and
H Ryan
October 1967,
The New Zealand medical journal,
J H Bett, and
R K Wilkinson, and
J Williams, and
H Ryan
June 1966,
Bollettino della Societa italiana di biologia sperimentale,
